Par Pharmaceutical
From Wikipedia, the free encyclopedia
| Par Pharmaceutical Companies, Inc. | |
| Type | Public NYSE: PRX |
|---|---|
| Founded | (1978) |
| Headquarters | Woodcliff Lake, New Jersey, United States |
| Industry | Pharmaceuticals |
| Products | >110 Generic and branded specialty pharmaceuticals |
| Revenue | $433,200,000 USD (2005) |
| Net income | $12,600,000 USD (2005) |
| Employees | 775 (2005) |
| Website | http://www.parpharm.com |
Par Pharmaceutical develops, manufactures and markets generic and branded specialty pharmaceuticals. Par was founded in 1978 and initially traded on the New York Stock Exchange in 1987. Par is currently the fifth largest generic pharmaceutical company in the United States.[1]
Contents |
[edit] Facilities
The company is based in the United States, with corporate headquarters in Woodcliff Lake, New Jersey and additional facilities for research, manufacturing and distribution in Suffern, New York, Spring Valley, New York and Somerset, New Jersey.
[edit] Products[2]
as of Nov 2006
[edit] References
- ParFacts. Par Pharmaceutical Companies, Inc. Retrieved on November 23, 2006.
- Company Milestones. Par Pharmaceutical Companies, Inc. Retrieved on November 23, 2006.
[edit] Notes
- ^ Introduction for Investors. Par Pharmaceutical Companies, Inc. Retrieved on November 23, 2006.
- ^ Products. Par Pharmaceutical Companies, Inc. Retrieved on November 24, 2006.
